Skip to main content
OpenTrials
Completed

NCT Number: NCT05566405

The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy

Prostate cancer is one of the most commonly diagnosed neoplasm in men worldwide. The gold standard of therapy is radical prostatectomy, a wide surgical excision of the neoplasm and can be performed either open, laparoscopic or robotic. The open retropubic approach, still performed today, can be completed under either general anaesthesia or combined (spinal/epidural) anaesthesia without any clear guideline on which one should be preferred.

In this study the investigators aim to evaluate general anaesthesia and combined (spinal/ epidural) anaesthesia in patients undergoing open retropubic radical prostatectomy and define whether these may have an impact on the oncological outcome and safety of the procedure.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Sismanoglio General Hospital

Marousi, Attica, 15126, Greece

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with localised prostate cancer
  • Eligible for open retropubic radical prostatectomy

Exclusion criteria

  • Metastatic prostate cancer
  • History of severe heart disease
  • History of haemostasis disorders
  • History of previous pelvic surgery
  • History of lung disease

Treatment and study plan

General anaesthesia

Procedure

All patients in the general anaesthesia group will be premedicated with intravenously administered (iv) midazolam (2mg) and fentanyl (100 mcg). Induction will be performed using intravenous propofol (2.5-3mg/kg) and lidocaine (40mg); dexamethasone 8mg, metoclopramide 10mg and omeprazole 40mg will also be administered. After successful tracheal intubation, total intravenous anaesthesia will be maintained by administering propofol (0.05 mg/kg/sec iv) and remifentanil (0.2 mcg/kg/sec iv). Pain management will be achieved by paracetamol (1g iv) and tramadol (100mg iv) whereas muscle relaxation by vecuronium (0.6 mg/kg iv).

Combined (Epidural and Spinal) Anaesthesia

Procedure

Combined (epidural and spinal) anaesthesia will be performed using an epidural 18G needle and a spinal 27G needle, in the L2-L3 or L3-L4 interspace. Induction will be carried out by spinal intrathecal administration of levobupivacaine (2.6-3ml of 0.5%) and mild sedation by midazolam (5mg iv in bolus). All patients will be administered dexamethasone 8mg, metoclopramide 10mg and omeprazole 40mg iv. Maintenance will be performed 75 minutes after induction and obtained using an epidural administration of levobupivacaine (4-5ml of 0.5%).

Open Retropubic Radical Prostatectomy

Procedure

All patients will undergo a nerve-sparing open retropubic radical prostatectomy

Primary outcomes

  1. Blood Pressure Change

    Time frame: Peri-operatively

    Measurement of patients systolic and diastolic blood pressure during the operation and post-operatively for 72 hours.

  2. Heart Rate Change

    Time frame: Peri-operatively

    Measurement of patients Heart Rate during the operation and post-operatively for 72 hours.

  3. Surgical APGAR Score

    Time frame: Peri-operatively

    Calculation of the Surgical APGAR score for each patient during surgery. The lower the score, on a scale of 1-10, the worst the prognosis of the patient.

    SAS is calculated using three variables:

    • Estimated blood loss (on a 0-3 scale, 0 points >1000 ml, 1 point 601-1000ml, 2 points 101-600 ml, 3 points <100ml)
    • Lowest mean arterial pressure (on a 0-3 scale, 0 points <40 mmHg, 1 point 40-54 mmHg, 2 points 55-69 mmHg, 3 points >70 mmHg)
    • Lowest heart rate (on a 0-4 scale, 0 points >85 bpm, 1 points 76-85 bpm, 2 points 66-75 bmp, 3 points 56-65 bmp, 4 points <55 bmp) during surgery.
  4. Blood Loss During Surgery

    Time frame: Peri-operatively

    Measured from suction contents intra-operatively in ml

  5. Haemoglobin Change

    Time frame: Peri-operatively

    Haemoglobin measurement before the operation and at 12-, 24- and 48-hours post-operatively, in g/dL

  6. Operation Time

    Time frame: Peri-operatively

    Time required for:

    • Induction of anaesthesia
    • Completion of the operation
    • Post-operative time until the patient is successfully transferred to the recovery room
  7. Pain Assessed by the VAS Scale

    Time frame: Peri-operatively

    Measured using a pain Visual Analogue Scale (VAS) at 6-, 24- and 48-hours after the operation.

    VAS is a self-reporting pain scale based on a 0 to 10-point system, with each point measuring 10mm on a linear line. Every patient was asked to indicate his pain levels from "No Pain" (equals 0) to "Worst Pain Imaginable" (equals 10).

  8. Complication Rate

    Time frame: Peri-operatively and up to 1 year after the operation

    Complications related to the procedure:

    • Intraoperative bleeding
    • Post-operative bleeding
    • Bowel perforation
    • Cardiovascular
    • Respiratory

    Complications related to the anaesthesia technique performed:

    • Post-operative headache
    • Nausea and vomiting
    • Any signs of potential nerve damage (manifested as inability to gain leg motility)
  9. Change From Baseline PSA Levels at 6-months

    Time frame: 6 months post-operative

    Measurement of Prostatic Specific Antigen (PSA) levels at 6 to establish a PSA nadir value

  10. Change from 6-month PSA Levels at 12-months

    Time frame: 12 months post-operative

    Measurement of Prostatic Specific Antigen (PSA) levels at 12 post-operation to detect any biochemical recurrence

Secondary outcomes

  1. Change from Baseline Erectile Function after Radical Prostatectomy

    Time frame: Up to 1 year after the operation

    Measured using the International Index of Erectile Function (IIEF-5) questionnaires pre-operatively and at 3-, 6- and 12-months post-surgery.

    The test is composed of 5 questions with 5 points for each question. Patients are evaluated accordingly:

    • Score 22 or more = No Erectile Disfunction
    • Score 17-21 = Mild Erectile Disfunction
    • Score 12-16 = Mild to moderate Erectile Disfunction
    • Score 8-11 = Moderate Erectile Disfunction
    • Score 7 or less = Severe Erectile Disfunction

    Results will be:

    • Analysed and compared to evaluate any potential difference of the two methods of anaesthesia, on post-operational erectile function
    • Analysed comparing pre-operation with post-operation questioners overall, to evaluate erectile disfunction after radical prostatectomy regardless of method of anaesthesia.
  2. Post-operative Urinary Incontinence

    Time frame: 1 year after the operation

    Measured using the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form at 12 months post-surgery.

    The Questionnaire is consisted of 4 questions:

    • Frequency "How often do you leak urine?" on a scale of 0 (never) to 5 (all the time)
    • Amount of leakage "How much urine do you leak?" on a scale to 0 (none) to 3 (a large amount)
    • Overall impact on quality of life "How much does it interfere with your life?" on a scale of 0 (not at all) to 10 (a great deal)
    • Timing of leakage "When does urine leak?"
  3. Total Hospital Stay

    Time frame: Peri-operative

    Days until patient discharge from the hospital.

  4. Patient Satisfaction Assessed by the Short Assessment of Patient Satisfaction (SAPS) Questionnaire

    Time frame: Peri-operative

    Satisfaction, using the Short Assessment of Patient Satisfaction (SAPS) Questionnaire, is measured in a scale of 0 to 28, with 0 to 10 equals to "Very Dissatisfied", 11-18 equals to "Dissatisfied", 19-26 equals to "Satisfied" and 27-28 equals to "Very Satisfied"

Sponsors and collaborators

Lead sponsor

Sismanoglio General Hospital

Other

Collaborators

  • National and Kapodistrian University of Athens

Registry information

Official study title

Comparative Study of the Effects of Combined Spinal Anaesthesia and General Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy in Patients With Localised Prostate Cancer

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Oct 4, 2022
Registry last updated
Oct 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.